By Saul L. Neidleman and Allen I. Laskin (Eds.)
Read or Download Cumulative Subject Index PDF
Best science (general) books
Advances in Food and Nutrition Research, Vol. 42
Advances in foodstuff and meals examine acknowledges the imperative dating among the nutrients and dietary sciences and brings jointly remarkable and complete studies that spotlight this courting. Contributions element the medical advancements within the vast parts encompassed by way of the fields of meals technological know-how and meals and are meant to make sure that meals scientists in educational and in addition to expert nutritionists and dieticians are saved trained relating rising study and advancements in those very important disciplines.
Advances In Atomic, Molecular, and Optical Physics, Vol. 42
This sequence, proven in 1965, is worried with fresh advancements within the basic quarter of atomic, molecular, and optical physics. the sphere is in a country of swift development, as new experimental and theoretical strategies are used on many aged and new difficulties. issues coated additionally contain similar utilized parts, reminiscent of atmospheric technology, astrophysics, floor physics, and laser physics.
Cyber Situational Awareness: Issues and Research
This day, whilst a safety coincidence happens, the pinnacle 3 questions defense directors could ask are in essence: What has occurred? Why did it ensue? What may still I do? solutions to the 1st questions shape the "core" of Cyber Situational information. additionally, no matter if the final query will be good replied, is drastically established upon the cyber situational wisdom potential of businesses.
- Covering And Surrounding
- Russian Messianism: Third Rome, Holy Revolution, Communism and After (Routledge Advances in European Politics)
- Parallel Computing: Architectures, Algorithms and Applications
- Intelligence: A Unifying Construct for the Social Sciences
Additional info for Cumulative Subject Index
Sample text
Rnyxogenes gum, production and properties, 23:34 Azotobacter vinelandii alginic acid production by, 23:28-29 hydrogen production technology and, 38~247-248 Azotobacter xylinurn sucrose phosphorylase activity, 32166 AZT, see Zidovudine B Bacillomycin L, 24:199 Bacillus a-amylase production and, 35:7, 8, 10-12 enzyme characteristics, 35:40, 41 recovery, 35:39 yields, 35:35, 36 growth, 35:34, 35 incubation, 35:33 industrial production, 35:14, 15, 17 moisture, 3529 pH, 35:30 present status, 35:18-21, 24 research needs, 35:43-45 B.
40:143-145 examples, 40:145-148 process systems approach, 40:99-107 overview, 40:95-96 product development, 40:156-173 constraints, 40:156-159 delivery concepts, 40:162-164 examples, 40:166-173 environmental services, 4 0 3 72-1 73 insulin discovery and development, 40:169-172 from penicillin to new class of antibiotics, 40:166-169 microbial route development, 40:165-166 product formulation, 40:162-164 resource statistics, 40:159-162 25 funnel diagram, 40:160-161 inverted triangle concept, 40:161-162 pipeline concept, 40:159-160 strategies, 40156-159 discovery, 40115-141 approaches, 40:131-140 classification, 40:115-120 versus manufacturing routes, 40:121-125 new chemical class discovery, 40: 125-1 2 7 other industrial sector products, 40:128-131 plant product discovery, 40:127-128 screens, 40:115-121 serendipity, 40:140 top 20 drugs, 40:140-141 regulation of genetically engineered microorganisms, 402 74-280 crop improvement plants, 34282-289 tissue culture, 34281 embryo transfer, 34297, 300 energy, 34277, 280 enzymes, 34276-279 foodborne yeasts and, 36:180 gibberellins and, 34:llO human protein, 34:289, 290 growth hormone, 34:291 insulin, 34:291 interferon, 34991 interleukin-2, 34:292 recombinant DNA, 34293 renin, 34:292 tissue plasminogen activator, 34291, 292 industrial organism, 34264-269 inherited diseases, 34296-299 microbial enzyme use in, 25:18-22 monoclonal antibodies, 34:294, 295 pollutants, 34:275 processes, environment and, 36:67-68, 82 case studies, 36:75-76 agriculture, 36:79-80 chemical bioprocesses, 36:78-79 food bioprocesses, 36:76-77 mining, 36:79 26 CUMULATIVE SUBJECT INDEX Biotechnology (continued) pharmaceutical bioprocesses, 36:77-78 waste treatment, 36:78 ecology, 36:69 dispersion, 36:69-70 genetic exchange, 36:71-73 survival, 36:70 hazards, 36:68-69 motivation, 3669 regulation, 3680-82 risk assessment, 3673-74 human, 36:74-76 protein analysis and, 36:323-324 technology protein chemistry, 34274, 275 recombinant DNA, 34:269-271 reverse genetics, 34271-274 vaccines, 34292, 294 Biotin antibody technologies and, 38:162, 190 antimetabolites, 22163 actithiazic acid, 22164-166 adenine, 22:169-170 amiclenomycin, 22168-169 a-dehydrobiotin, 22:166-167 a-methylbiotin, 22167-168 a-methyldethiobiotin, 22167-168 stravidin, 22:16&169 bacterial gene transfer in soil and, 35:95, 146, 147, 149, 151 biosynthetic pathways to, 22146-148 biotin synthesizing reaction, 22:147, 153-155 dethiobiotin synthetase, 22:147, 151-153 7,8-diaminopelargonic acid, 22147, 149-151 7-keto-8-aminopelargonic acid, 22147, 149 pimilyl-CoA synthetase, 22148 chemical synthesis of, 22158-159 microbial degradation of,22170-172 microbial synthesis of, 22160-161 protein analysis and, 36294 regulation of biotin synthesis, 2 2 3 55-1 57 uses of, 22:146 Biotransformation environmental, 40:289-300 dicamba, 40291-295 other chlorinated and nonchlorinated compounds, 40:295-300 by immobilized plant cells, 2814-22 process discovery, 40:143-145 sterol, 39:62-63 Biotyping, 33:48, 49 Biparental mating, recombinant E.
Peucetius mutants, 32209-210 production by S. 82 foodborne yeasts and, 36231-232 genetically engineered microorganisms and, 38:36 herbicides and pesticides and, 3636, 42 CUMULATIVE SUBJECT INDEX pBR322, 36:92, 97, 99 phenotypes with, genetically engineered microorganisms and, 38:32-35 recombinant E. coli K-12 and, 36105, 109,115,116-117,120,121 selection, 36:97-98 water, 36:102-103 Antibiotics 33-25, 24201-202 AB-1, 24:203 A-3302-B, 24~212 a-amylase production and, 35:lO anoxygenic phototrophic bacteria and, 38280 antibody technologies and, 38195 autotoxic, tolerance to, in producer organisms, 25:152-162 bacterial gene transfer in soil and, 35:62, 64 conjugation, 35:75, 77, 79, 80, 83 study methods, 35:122-125, 128 environmental factors, 35:67, 70 recombinants, 35:140-142 transduction, 35:102, 137, 138 biotechnology and, 34264, 280, 281 BU 1880,24:203 chorismate-derived production of, 25:75-93 common subunits of, 27:59 culture resistance to, 25:76-81 development of, 33:327 EM-49,24199-202 enzyme inactivation of, 25:78-80 extraction procedure, 33:326-330 feedback control of, 25:162-164 Ganoderrna, 37:102, 123 genetically engineered microorganisms and, 38:69, 91 gibberellins and, 3488, 101 product development, 40:166-169 secondary metabolism and, 34:5, 7-9, 12 similar subunit structures in, 28:33 substances from bacteria, 41:202-203 from fungi and ascomycetes, 34242, 243 basidiomycetes, 34238, 240, 241 fungi imperfecti, 34230-232, 234, 236 11 history, 34:184 phycomycetes, 34244 production, 34186-206 screening, 34:185 target-site modification by, 25:152-157 TL-119, 2 4 2 11-2 1 2 TM-743, 24~203 tolerance to by excretion-exclusion, 25:157-162 in producer organisms, 25:147-168 V-8495, 24~203 xenobiotics and, 35917 xenotoxic, 25:149-152 Antibodies anoxygenic phototrophic bacteria and, 38251 biotechnology and, 34:290, 292, 294 cellular cytotoxicity dependence on, antibody technologies and, 38:171, 175, 181 Ganoderrna, 37:118-119 hydrodynamic shear stress, 37201 labeling, hydrodynamic shear stress, 37:189 levan and, 35:180, 190 microbial cytochromes P450 and, 36:146, 151, 163 protein analysis and, 36291, 294, 316, 318, 323 Antibody technologies affinity chromatography, 38:160-161 enzyme immunoassay, 38:187-191 future, 38:194-195 high-performance liquid chromatography, 38:158-159 history, 38:150-15 1 immunofluorescence, 38:186-187 immunoglobulin-binding proteins, 38~157-158 immunotherapy, 38:180 cancer, 38:181-182 immunoglobulin fragments, 38:180-181 immunotoxins, 38:182-183, 185 Pseudomonas exotoxin, 38:184-185 ricin, 38:183-184 monoclonal antibodies, 38161-162 bispecificity, 38166-167 catalytic antibodies, 38167-170 fusion, 38:162 12 CUMULATIVE SUBJECT INDEX Antibody technologies (continued) hybridomas, 38163-164 nonmurine, 38164-165 specificity, 38:165-166 polyclonal antibodies adjuvants , 3 8153-1 55 delivery, 38:155 idiotypes, 38:155-157 lipid-derivatized antibodies, 38:155 synthetic peptides, 38:151-153 precipitation, 38:158 radiolabels, 38:186 recombinant antibodies eukaryotes, 38:171-172 heterochimeras, 38:174-175 homochimeras, 38:175-177 libraries, 38:172-174 mutagenesis, 38:174 prokaryotes, 38170-1 71 single chain, 38:177-179 size, 38:179-180 recombinant DNA affinity purification, 38:192 epitope mapping, 38:192-194 immunoscreening, 38:191-192 transplactation, 38181 Antiflammatory activity, Gonoderrno, 37:119-120 Antifoams adverse effects of, 33:189-191 carriers, 33:185, 189 characteristics, desired, 33:187-188 chemical, for fermentations, 33:181-184 combined with other defoaming methods, 33:211-213 definition of, 33:180 foam breakage mechanisms of, 33:185-186 oxygen transfer rate and, 33:191-192 selection criteria, 33:186-189 type and nature of, 33:180-185 Antifungal agents, from streptomycetes, tolerance to, in producer organisms, 25:152 Antigens antibody technologies and, 38:150, 187, 192,194 enzyme immunoassay, 38:187-189, 191 immunotherapy, 38:180-182 monoclonal antibodies, 38:162, 164-167,169-170 polyclonal antibodies, 38:151-156 recent developments, 38:160 recombinant antibodies, 38:174-177, 17S180 bacterial gene transfer in soil and, 35:151 biotechnological processes and, 36:77 biotechnology and, 34:290, 292, 294, 295 foodborne yeasts and, 36:180 Ganoderma, 37:118 levan and, 35:180, 190 microbial cytochromes P450 and, 36:163 protein analysis and, 36:291, 316, 323 recombinant E.
